No connection

Search Results

SLGL

BEARISH
$73.87 Live
Sol-Gel Technologies Ltd. · NASDAQ
Target $110.0 (+48.9%)
$4.11 52W Range $97.97

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 20, 2026
Market cap
$239.73M
P/E
N/A
ROE
-23.7%
Profit margin
-31.6%
Debt/Equity
0.04
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
SLGL exhibits a critical disconnect between its explosive 1-year price appreciation (+1243%) and its deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While revenue growth is exceptional at 150%, the company suffers from negative gross margins (-17.62%) and a catastrophic operating margin (-497.84%), indicating that the cost of producing its goods exceeds its sales revenue. Despite a strong liquidity position (Current Ratio 4.37) and low debt, the valuation is speculative with a Price/Book of 9.02 and a Price/Sales of 12.36. The stock is currently trading on growth momentum rather than financial viability.

Key Strengths

Explosive YoY revenue growth of 150.40%
Very low leverage with a Debt/Equity ratio of 0.04
Strong short-term liquidity (Current Ratio 4.37)
Significant 1-year price momentum
Positive analyst target price of $110.00

Key Risks

Negative gross margins indicate a non-viable cost structure
Severe operational inefficiency (Operating Margin -497.84%)
Extremely low Piotroski F-Score (2/9) signaling financial weakness
Excessive valuation premiums (P/B 9.02, P/S 12.36)
Negative YoY EPS growth (-251.4%) despite revenue gains

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
28
Weak
Value
15
Future
65
Past
40
Health
20
Dividend
0
AI Verdict
Speculative Bubble
Key drivers: Revenue growth vs. Profitability gap, Piotroski F-Score failure, Extreme valuation multiples
Confidence
90%
Value
15/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • P/B of 9.02 is excessive
  • P/S of 12.36 is unsustainable for negative margin firms
  • No Graham Number available due to lack of earnings
Future
65/100

Ref Growth rates

Positives
  • Triple-digit revenue growth
  • High analyst target price
Watchpoints
  • Inability to convert revenue to profit
  • Negative forward P/E
Past
40/100

Ref Historical trends

Positives
  • Massive 1Y price return
Watchpoints
  • Negative 5Y change (-48.3%)
  • Inconsistent earnings track record
Health
20/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Low Debt/Equity
  • High Current Ratio
Watchpoints
  • Piotroski F-Score 2/9 (Weak)
  • Negative ROE and ROA
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$73.87
Analyst Target
$110.0
Upside/Downside
+48.9%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for SLGL and closest competitors.

Updated 2026-04-17
SLG
Sol-Gel Technologies Ltd.
Primary
5Y
-48.3%
3Y
+88.0%
1Y
+1243.1%
6M
+82.0%
1M
-1.9%
1W
-1.3%
SPO
Spok Holdings, Inc.
Peer
5Y
+73.7%
3Y
+21.1%
1Y
-19.9%
6M
-23.7%
1M
+2.4%
1W
+3.5%
PRO
Profound Medical Corp.
Peer
5Y
-66.8%
3Y
-41.5%
1Y
+39.1%
6M
+20.2%
1M
+21.6%
1W
+11.8%
CAM
CAMP4 THERAPEUTICS CORPORATION
Peer
5Y
-56.6%
3Y
-56.6%
1Y
+78.8%
6M
+41.3%
1M
-25.9%
1W
+5.4%
ALE
Alector, Inc.
Peer
5Y
-88.2%
3Y
-66.9%
1Y
+53.9%
6M
-20.0%
1M
+14.6%
1W
+10.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-10.85
PEG Ratio
N/A
P/B Ratio
9.02
P/S Ratio
12.36
EV/Revenue
9.52
EV/EBITDA
-24.66
Market Cap
$239.73M

Profitability

Profit margins and return metrics

Profit Margin -31.6%
Operating Margin -497.84%
Gross Margin -17.62%
ROE -23.72%
ROA -14.43%

Growth

Revenue and earnings growth rates

Revenue Growth +150.4%
Earnings Growth N/A
Q/Q Revenue Growth +150.36%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.04
Low debt
Current Ratio
4.37
Strong
Quick Ratio
4.21
Excellent
Cash/Share
$8.54

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Op. Margin
-490.1%
Net Margin
-429.2%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.31x

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-01
$N/A
2026-03-19
$-1.06
-371.8% surprise
2025-11-20
$-2.13
-1.9% surprise
2025-08-15
$4.17
+695.7% surprise

Healthcare Sector Comparison

Comparing SLGL against 470 companies in the Healthcare sector (26 bullish, 143 neutral, 301 bearish)
Return on Equity (ROE)
-23.72%
This Stock
vs
-97.91%
Sector Avg
-75.8% (Below Avg)
Profit Margin
-31.6%
This Stock
vs
-16.16%
Sector Avg
+95.5% (Superior)
Debt to Equity
0.04
This Stock
vs
3.0
Sector Avg
-98.6% (Less Debt)
Revenue Growth
150.4%
This Stock
vs
142.9%
Sector Avg
+5.2% (Growing)
Current Ratio
4.37
This Stock
vs
4.65
Sector Avg
-6.0% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2026-03-24
39,665 shares · $2,855,880
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2026-02-13
291 shares · $18,333
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2026-02-02
100 shares · $5,800
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2026-02-02
100 shares · $5,800
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2026-01-27
100 shares · $5,705
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2026-01-23
3,324 shares · $187,356
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2026-01-05
2,592 shares · $108,858
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-12-31
66,304 shares · $2,782,904
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-12-26
2,905 shares · $120,533
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-12-17
2,735 shares · $110,412
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-12-12
87 shares · $3,480
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-12-08
744 shares · $29,469
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-12-03
6,864 shares · $257,610
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-11-26
949 shares · $37,933
OPALEYE MANAGEMENT, INC.
Beneficial Owner of more than 10% of a Class of Security
Buy
2025-11-20
5,784 shares · $207,244
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

20-F
20-F
2026-03-19

SLGL filed its 20-F annual report on March 19, 2026. This filing provides the company's comprehensive annual financial disclosures and risk assessments for the fiscal period.

20-F
20-F
2025-04-29

SLGL filed its 20-F annual report on April 29, 2025. Specific financial highlights and risk factors were not provided in the available metadata, but the filing serves as the company's comprehensive annual disclosure for foreign private issuers.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
1 analysts
HC Wainwright & Co.
2026-01-20
Maintains
Buy Buy
HC Wainwright & Co.
2025-12-22
reit
Buy Buy
HC Wainwright & Co.
2025-10-27
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning SLGL from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile